Navigation Links
The University of Nottingham in the British Midlands Announces Breakthrough in Parkinson's Disease Research
Date:8/27/2008

Award Winning Research Team Makes Crucial Breakthrough in Battle to Prevent

Onset of Parkinson's Disease

CHICAGO, Aug. 27 /PRNewswire/ -- The British Midlands Development Corporation today announced that scientists at The University of Nottingham have made a crucial breakthrough in the battle to slow or prevent the onset of a very common type of dementia and Parkinson's disease.

The researchers have genetically produced the first ever mouse model with the type of brain degeneration, or nerve cell loss, seen in Lewy body disease and Parkinson's disease, which could lead to more targeted drugs to treat the degenerative conditions.

The study has been carried out by Professor John Mayer and Dr Lynn Bedford in the University's School of Biomedical Sciences, in collaboration with Professor Jim Lowe in the School of Molecular Medical Sciences.

Professor John Mayer said: "Current drugs given to people with Lewy body and Parkinson's disease simply treat the symptoms. This model is the first platform to understand how the brain cell deterioration takes place. We will use this model to identify targets for new drugs to slow or prevent the disease."

Lewy body disease, also known as dementia with Lewy bodies (DLB) shares characteristics with both Alzheimer's and Parkinson's diseases. The number of people with dementia is forecast to double within a generation.

Dr Kieran Breen, Director of Research and Development at the Parkinson's Disease Society, added: "The formation of Lewy bodies is a key event in the development of nerve cell death associated with Parkinson's disease. Understanding how these are formed will help us to figure out what happens when nerve cells die in Parkinson's and from this to develop therapies that will ultimately provide a cure for the condition."

"Universities in the Midlands continue to set the bar in innovation and discovery," said Vern Sebby, President and CEO of British Midlands Development Corporation, "The British Midlands is one of Europe's premier locations for the advancement of medicine and life sciences. All of the region's 18 universities have unique areas of scientific expertise, which fuel the region's record of innovation in the field."

About British Midlands Development Corporation

The British Midlands Development Corporation is the North American economic development agency for central England. The Midlands region is located just one hour to the north of London and includes the major commercial centers of Birmingham, Nottingham, Coventry and Northampton.

As an agency funded by the UK Government, The British Midlands Development Corporation provides specialist advice and support to North American companies seeking to establish a presence or expand a current operation in the region.

The British Midlands Development Corporation is based in Chicago with branch offices in Boston, Washington, DC and San Jose.

For more information, please visit our website at http://www.thebritishmidlands.com.

Press Contact

Laura Nicholas

laura@thepontgroup.com

646 290 5989


'/>"/>
SOURCE British Midlands Development Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. Boston University and The Center for Human Genetics, Inc. Announce Change in Testing Services
2. First U.S. Patient to Receive New Heart-Assist Device Doing Well After Surgery at University of Michigan
3. University of Rochester Researcher Named Millennium Pharmaceuticals Career Development Scholar of The Leukemia & Lymphoma Society
4. Terumo Heart Obtains IRB Approval from the University of Michigan to Initiate DuraHeart(TM) Left Ventricular Assist System U.S. Pivotal Trial
5. Orion Genomics Gains Exclusive Worldwide Rights to the IGF2 Gene for Colorectal Cancer Risk Testing Through Licensing Agreement With Johns Hopkins University
6. CellCyte Genetics Corporation Selects Washington University School of Medicine to Perform Study on CellCytes Glycoprotein Products in Heart Attack Disease Model
7. University of Miami Team Confirms Value of Monitoring Cell-Mediated Immunity Pre- and Post-Transplant in Management of Kidney Transplant Recipients
8. Kiadis Pharma Announces Collaboration With the Julius Maximilians University of Wurzburg, Germany
9. CellCyte Genetics Signs Collaborative Agreement With Northwestern Universitys Feinberg School of Medicine to Perform Disease Model Outcome Study of CellCytes CCG-TH30 Product Candidate
10. Infant Vaccines Produce Autism Symptoms in New Primate Study by University of Pittsburgh Scientists
11. BASF Officially Launches the Collaborative Advanced Research Initiative at Harvard University
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... 2016 Research and Markets has announced ... Forecast to 2022" report to their offering. ... the patients with kidney failure, it replaces the function of ... patient,s blood and thus the treatment helps to keep the ... balance. Increasing number of ESRD patients & ...
(Date:6/23/2016)... , June 23, 2016 Research and ... Devices Medical Market Analysis 2016 - Forecast to 2022" ... The report contains up to date financial data derived ... Assessment of major trends with potential impact on the market ... of market segmentation which comprises of sub markets, regional and ...
(Date:6/23/2016)... RIDGE, Ill. and INDIANAPOLIS ... of students receiving a Lilly Diabetes Tomorrow,s Leaders Scholarship ... The 2016 scholarship winners, announced today online at ... to let type 1 diabetes stand in the way ... Diabetes has supported the Foundation,s scholarship program since 2012, ...
Breaking Medicine Technology:
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... Austin residents ... the American College of Mohs Surgery and to Dr. Russell Peckham for medical and ... highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed ...
(Date:6/25/2016)... ... 2016 , ... First Choice Emergency Room , the largest network of ... Medical Director of its new Mesquite-Samuell Farm facility. , “We are pleased to ... said Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. ...
(Date:6/25/2016)... ... ... On Friday, June 10, Van Mitchell, Secretary of the Maryland Department of Health ... of their exemplary accomplishments in worksite health promotion. , The Wellness at Work Awards ... at the BWI Marriott in Linthicum Heights. iHire was one of 42 businesses to ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced ... feelings, many turn to unhealthy avenues, such as drug or alcohol abuse, as a ... has released tools for healthy coping following a traumatic event. , Trauma sufferers tend ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary Hypertension Association (PHA) ... will receive two significant new grants to support its work to advance research ... anniversary by recognizing patients, medical professionals and scientists for their work in fighting ...
Breaking Medicine News(10 mins):